The FDA has received 1,878 adverse event reports for cats that name Mirtazapine.
- 1,878 reports name Mirtazapine in cats, which is 1.2% of all 151,164 cat reports. A report counts under every active ingredient it names.
- 46% are marked serious and 21% record a death or euthanasia; across all cat reports those figures are 27% and 9.4%.
- 16% are complaints that the product did not work (19% across all cat reports).
- The clinical signs reported most are lack of efficacy, death by euthanasia and vomiting.
- The FDA lists 1 approved animal drug application containing Mirtazapine for cats, the earliest approved in 2018.
- None of this is a rate. The FDA data does not record how many cats were given Mirtazapine, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All cat reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 857 | 46% | 27% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 394 | 21% | 9.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 309 | 16% | 19% |
| Seizurea seizure or convulsion is among the clinical signs | 65 | 3.5% | 2.6% |
| Not used per labelthe report says the product was not used the way its label directs | 1,255 | 67% | 33% |
Where on the body do the reported signs sit?
Not on the body: Whole body 20% Did not work 8.4%
- Stomach and gut30%vomiting, weight loss, not eating, anorexia and 2 more
- Whole body20%death by euthanasia, lethargy, death, lethargy
- Where it was applied13%application site reddening, application site crust, application site irritation, application site erythema
- Blood and organ tests12%elevated blood urea nitrogen (bun), hyperglycaemia, other abnormal test result, anaemia and 1 more
- Behaviour10%behavioural disorder, vocalisation, hiding
- Did not work8.4%lack of efficacy
- Brain and nerves3.1%ataxia
- Thirst and urination3.0%dehydration
Each figure is a share of sign mentions among the 25 signs reported most for Mirtazapine in cats. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Lack of efficacy273 15%
- Death by euthanasia242 13%
- Vomiting225 12%
- Weight loss184 9.8%
- Not eating171 9.1%
- Application site reddening156 8.3%
- Anorexia151 8.0%
- Lethargy151 8.0%
Reports received per year
Is it approved for cats?
The FDA lists 1 approved animal drug application containing Mirtazapine for cats, the earliest approved in 2018.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| MiratazDechra Veterinary Products LLC | Transdermal ointment RX | Cat | 2018 | 141-481 |
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. See Mirtazapine in dogs (289 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Gabapentin in cats1,956
- Pyrantel in cats2,023
- Carprofen in cats1,711
- Enrofloxacin in cats1,644
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.